The underlying cause of male infertility is unknown for 30 percent of cases. In a pair of new studies, researchers at University of California San Diego School of Medicine determined that the reproductive homeobox (RHOX) family of transcription factors — regulatory proteins that activate some genes and inactivate others — drive the development of stem cells in the testes in mice. The investigators also linked
RHOX gene mutations to male infertility in humans. The mouse study is published September 27 by
Cell Reports and the human study was published September 15 by
Human Molecular Genetics.
Mutations in the RHOX transcription factor family inhibit sperm development and are associated with infertility in men.
“Infertility in general, and especially male fertility, gets little attention considering how common of a problem it is — about 15 percent of couples are affected, and nearly half of these cases are due to male infertility,” said Miles Wilkinson, PhD, professor of reproductive medicine at UC San Diego School of Medicine and senior author of the
Cell Reports study. “That means around 7 percent of all males of reproductive age — nearly 4 million men in the U.S. — have fertility problems.” Wilkinson is also a co-author of the
Human Molecular Genetics study, which was led by Jörg Gromoll, PhD, at the University of Münster in Germany.
Sperm are made from cells that undergo many stages. Transcription factors have been identified that direct most of these cell stages, from the dividing cells in the embryo to the cells that rearrange and partition the chromosomes to individual “pre-sperm” in the testes. However, before this latest research, Wilkinson said no transcription factors were known to direct one of the most critical stages — the formation of the stem cells in the testes, known as spermatogonial stem cells.
Cell Reports study, Wilkinson and team removed the entire cluster of 33 Rhox genes in mice. They were surprised to find that the most notable defect in these mice was a deficiency in spermatogonial stem cells. Hye-Won Song, PhD, assistant project scientist in Wilkinson’s lab and first author of the
Cell Reports study, removed just one of the
Rhox genes —
Rhox10 – and found essentially the same defect as deleting the full set.
Wilkinson, Song and team discovered there was nothing wrong with the spermatogonial stem cells in mice lacking
Rhox10, only that there were so few. They found that this occurred because most of the earlier stage cells — pro-spermatogonia — did not specialize into spermatogonial stem cells. As a result, the testes of
Rhox10-deficient mice did not enlarge and their sperm counts failed to increase as they aged.
The researchers concluded that
Rhox10 is the most critical gene in the
Rhox cluster, and that it plays a role in spermatogonial stem cell formation.
Rhox genes are on the X chromosome. It makes sense that male infertility would be caused by mutated genes on the X chromosome, Wilkinson said, because men only have one copy — if something goes wrong with an X-linked gene, they don’t have a backup, like women do.
There are several potential clinical implications of these results, the researchers said. For example,
Rhox genes may have roles in testicular tumors that arise from germ cells that failed to convert into spermatogonial stem cells and thus are “frozen” at the pro-spermatogonia stage.
Rhox genes may also be useful for regenerative medicine approaches to restoring fertility through therapy with spermatogonial stem cells.
In the second study, published by
Human Molecular Genetics, Gromoll and colleagues sequenced
RHOX genes in 250 men with severely low sperm count. They found two mutations in one of these genes (RHOXF1) and four mutations in the other two (RHOXF2 and
RHOXF2B, which are almost identical). Only one mutation was also found in a control group of men with normal sperm concentrations.
In laboratory experiments, the researchers found that one of the low sperm count-associated mutations significantly impaired transcription factor RHOXF2/2B’s ability to regulate its target genes. Molecular modeling suggested that this mutation altered its 3-D structure.
“Spermatogonial stem cells allow men — even in their 70s — to generate sperm and father children,” said Song, who also co-authored the
Human Molecular Genetics study. “Our finding that
Rhox10 is critical for spermatogonial stem cells, coupled with the finding that human
RHOX genes are mutated in infertile men, suggests that mutations in these genes cause human male infertility.”
This conclusion is further underscored by the previous finding that men with abnormal sperm characteristics tend to have
RHOX genes excessively marked with chemical tags known as methyl groups. Wilkinson, Song and team are now working to better understand precisely how variations in RHOX transcription factors lead to human infertility.
Co-authors of the
Cell Reports paper also include Anilkumar Bettegowda, Blue B. Lake, Adrienne H. Zhao, David Skarbrevik, Eric Babajanian, Eleen Y. Shum, Mimi H. Phan, Terra-Dawn M. Plank, Marcy E. Richardson, Madhuvanthi Ramaiah, Vaishnavi Sridhar, Kun Zhang, UC San Diego; Meena Sukhwani, Kyle E. Orwig, University of Pittsburgh; and Dirk G. de Rooij, Utrecht University.
This research was funded, in part, by the National Institutes of health (R01-GM119128) and CIRM (RB5-07210).
Co-authors of the
Human Molecular Genetics paper also include Jennifer Borgmann, Sabine Kliesch, Sandra Laurentino, University of Münster; Frank Tüttelmann, Bernd Dworniczak, and Albrecht Röpke, Institute of Human Genetics in Münster, Germany.
This research was funded, in part, by the German Research Foundation (GE1547/15-1) and Innovative Medizinische Forschung (I-LA121315).